Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.54 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.51 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3539943 | 1.00 | ALDH1A1 (0.58) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL13618841 | 0.88 | PDPK1 (0.66) | ALDH1A1TAS1R3TAS1R1TAS1R2PDPK1 | |
| SCHEMBL6850366 | 0.88 | PDPK1 (0.66) | ALDH1A1TAS1R3TAS1R1TAS1R2PDPK1 | |
| SCHEMBL2115700 | 0.84 | HTT (0.63) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL6344102 | 0.81 | HTT (0.59) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL15295177 | 0.81 | LMNA (0.55) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL1101136 | 0.81 | LMNA (0.55) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL5270795 | 0.81 | LMNA (0.55) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL18539244 | 0.81 | LMNA (0.55) | ALDH1A1LMNAHTTTAS1R3TAS1R1 | |
| SCHEMBL61094 | 0.81 | PDPK1 (0.79) | ALDH1A1LMNAHTTTAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2455075-A1 | Combinations of Eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, & Cognitive Disorders | Sepracor Inc. (US) | 2012-05-23 | — | — | EP | disclosed |